نتایج جستجو برای: viii

تعداد نتایج: 21094  

2014
N. Lebedeva P. Kuivalainen

Journal: :Thrombosis and haemostasis 2010
Ana-Maria Navarrete Suryasarathi Dasgupta Maud Teyssandier Yohann Repesse Sandrine Delignat Sébastien André Jagadeesh Bayry Srinivas V Kaveri Sébastien Lacroix-Desmazes

The immunogenicity of therapeutic factor VIII (FVIII) in patients with haemophilia A remains a critical issue in patient management. This review describes the immunological processes involved in the activation of the immune system against FVIII, with a particular focus on the role of endocytic receptors for the recognition of FVIII by antigen-presenting cells.

Journal: :The Journal of antibiotics 1995
T Sakai H Kawai M Kamishohara A Odagawa A Suzuki T Uchida T Kawasaki T Tsuruo N Otake

A series of SPM VIII analogs were synthesized to investigate the effect of the amino acid moiety on the antitumor activity. The L-threonine analog and the glycylglycine analog of SPM VIII showed much higher cytotoxicity to P388 murine leukemia cells (IC50 5.8 nM and 0.11 nM, respectively) than SPM VIII (IC50 25nM). However, replacement of the glycine moiety with other amino acids greatly reduce...

Journal: :Journal of virology 2008
Dror Avisar Alexey I Prokhnevsky Valerian V Dolja

The Hsp70 homolog (Hsp70h) of Beet yellows virus (BYV) functions in virion assembly and cell-to-cell movement and is autonomously targeted to plasmodesmata in association with the actomyosin motility system (A. I. Prokhnevsky, V. V. Peremyslov, and V. V. Dolja, J. Virol. 79:14421-14428, 2005). Myosins are a diverse category of molecular motors that possess a motor domain and a tail domain invol...

2003
Katrine Jokinen

.............................................................................................................................. I PREFACE.................................................................................................................................II TABLE OF CONTENTS ...................................................................................................... III ABBR...

Journal: :Annals of clinical and laboratory science 1986
J Lazarchick T M Stubbs L A Romein

It has been suggested that the basis for the marked discordance in factor VIII parameters in preeclampsia is the result of proteolysis of the factor VIII procoagulant component (VIII:C) owing to activation of the coagulation system. To investigate this further, levels were compared of factor VIII:C and VIII:C (Ag), the immunologic equivalent of the procoagulant activity, in a series of preeclam...

Journal: :The Journal of clinical investigation 1982
M B Hultin

The cofactor function of human Factor VIII in Factor X activation was investigated by an initial-rate assay of 3H-Factor X activation in the presence of human factor IXa, Ca2+, and either phospholipid or fresh washed human platelets. Purified Factor VIII that has not been activated by thrombin or Factor Xa supports Factor X activation after a lag of several minutes. A specific inhibitor of Fact...

Journal: :Arteriosclerosis, thrombosis, and vascular biology 1999
G Plenz A Dorszewski W Völker Y S Ko N J Severs G Breithardt H Robenek

Lipoproteins play a major role in cardiovascular disease and atherosclerosis. In the vascular wall, they strongly influence the organization of extracellular matrix. The present study set out to investigate the changes in the extracellular matrix of the vessel wall induced by atherogenic diet, focusing on type VIII collagen, a vascular collagen that has not previously been investigated in detai...

A series of non-cyclic polyethers with different end groups and chain length were used for the extraction of lithium salt from aqueous into various organic phases viz. Chloroform, Carbon tetrachloride, 1,2-dichloroethane, to study the influence of structural variations within the extractant molecule upon the extraction selectivity and efficiency. The ionophores used were viz. DEG (I), DEGDME (I...

Journal: :Blood 2014
Edward Tuddenham

To understand why this quest was so prolonged, one needs to go back to the technologies of the 1970s and 1980s. Factor VIII is a cofactor for conversion of factorX to factorXa by activated factor IX and is the rarest of all the clotting factors in blood. Not surprisingly, it was the last but one of the classical blood coagulation factors to yield to the advance of molecular biology (in 1984, 2 ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید